Healthcare -
Biotechnology - NASDAQ - US
$ 5.89
0.684 %
$ 252 M
Market Cap
-10.52
P/E
DMAC - TOTAL LIABILITIES
Total Liabilities DMAC - DiaMedica Therapeutics Inc.
3.1 M
LAST VALUE
42.55%
2 YEAR CAGR
18.75%
5 YEAR CAGR
7.37%
10 YEAR CAGR